The mean percentages of inflammatory cells expressing CXCL9, CXCL10, CXCL11 and CXCR3 in skin lesions from AOSD patients were 8.7% ± 10.5%, 24.5% ± 21.6%, 27.2% ± 24.3% and 15.2% ± 17.0%, respectively (Table 3). Here, CXCR3 is linked to adult-onset Still disease.